Literature DB >> 1405331

ACE inhibitors in renal disease.

H R Brunner1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1405331     DOI： 10.1038/ki.1992.311

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  10 in total

1.  Addition of angiotensin II type 1 receptor blocker to CCR2 antagonist markedly attenuates crescentic glomerulonephritis.

Authors:  Maki Urushihara; Naro Ohashi; Kayoko Miyata; Ryousuke Satou; Omar W Acres; Hiroyuki Kobori
Journal:  Hypertension       Date:  2011-01-31       Impact factor: 10.190

2.  Angiotensinogen Expression Is Enhanced in the Progression of Glomerular Disease.

Authors:  Maki Urushihara; Hiroyuki Kobori
Journal:  Int J Clin Med       Date:  2011-09-01

3.  Changes in urinary angiotensinogen posttreatment in pediatric IgA nephropathy patients.

Authors:  Maki Urushihara; Takashi Nagai; Yukiko Kinoshita; Sato Nishiyama; Kenichi Suga; Natsuko Ozaki; Ariunbold Jamba; Shuji Kondo; Hiroyuki Kobori; Shoji Kagami
Journal:  Pediatr Nephrol       Date:  2014-12-20       Impact factor: 3.714

4.  Dietary protein restriction in combination with angiotensin converting enzyme inhibitor improves insulin resistance in patients with chronic renal disease.

Authors:  K Stefíková; V Spustová; K Gazdíková; Z Krivosíková; R Dzúrik
Journal:  Int Urol Nephrol       Date:  1997       Impact factor: 2.370

5.  Pharmacokinetics and blood pressure response of losartan in end-stage renal disease.

Authors:  D A Sica; C E Halstenson; T W Gehr; W F Keane
Journal:  Clin Pharmacokinet       Date:  2000-06       Impact factor: 6.447

6.  Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice.

Authors:  Y Hisada; T Sugaya; M Yamanouchi; H Uchida; H Fujimura; H Sakurai; A Fukamizu; K Murakami
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

7.  Urinary angiotensinogen accurately reflects intrarenal Renin-Angiotensin system activity.

Authors:  Maki Urushihara; Shuji Kondo; Shoji Kagami; Hiroyuki Kobori
Journal:  Am J Nephrol       Date:  2010-02-15       Impact factor: 3.754

Review 8.  Augmented intrarenal and urinary angiotensinogen in hypertension and chronic kidney disease.

Authors:  Hiroyuki Kobori; Maki Urushihara
Journal:  Pflugers Arch       Date:  2012-08-24       Impact factor: 3.657

Review 9.  ACE inhibitors in elderly patients with hypertension. Special considerations.

Authors:  M Ravid; D Ravid
Journal:  Drugs Aging       Date:  1996-01       Impact factor: 3.923

Review 10.  ACE inhibitors. Differential use in elderly patients with hypertension.

Authors:  Z H Israili; W D Hall
Journal:  Drugs Aging       Date:  1995-11       Impact factor: 3.923
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.